FDA Inspection 1236215 — Agera Tobacco, Inc.
The FDA completed an inspection of Agera Tobacco, Inc. on March 6, 2024 in Anaheim, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Tobacco.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 6, 2024
- Fiscal Year
- 2024
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Anaheim, CA (United States)